Clinical trial for Stroke
Official title Art Therapy and Its Effect on Non-Motor Function Rehabilitation in the Subacute Phase of Stroke Recovery
ClinicalTrials.gov ID: NCT06713252
What this study is testing
- What it's testing
- The study wants to see if adding art therapy improves mood, thinking skills and social participation during the early recovery period after a stroke.
- What's involved
- Participants will take part in scheduled art therapy sessions that may include music, painting or dance, along with the usual stroke rehabilitation they are already receiving.
- Time commitment
- The study runs during the subacute phase after stroke and requires regular visits for the art therapy sessions over several weeks.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 to 75
You may be able to join if
- Study Participants: Stroke patients aged 40-75. Patients in this age group generally have a higher incidence of stroke and show relatively higher...
- Type of Stroke: First occurrence of ischemic or hemorrhagic stroke, confirmed by imaging (CT or MRI).
- Time Since Stroke Onset: Between 2 weeks and 3 months post-stroke (broadly defined subacute phase).
- Severity of Stroke Sequelae: Stroke sequelae should be mild to moderate (Modified Rankin Scale score of 2 to 3).
- Cognitive Ability: Participants must have basic cognitive function and be able to understand and comply with research requirements.
You likely can't join if
- Severe Mental Illness: A history or current diagnosis of severe mental disorders (e.g., schizophrenia, bipolar disorder) or a current severe level of...
- Severe Comorbidities: Patients with serious physical illnesses, such as advanced cancer, severe heart disease (e.g., heart failure, acute coronary...
- Severe Sensory Impairments: Patients with serious sensory impairments, such as blindness, profound hearing loss, or uncorrectable sensory deficits.
- Severe Language Impairments: Patients with severe aphasia or speech communication disorders that impede effective communication or expression.
- Substance Dependence or Abuse History: Patients with a current history of substance dependence or abuse (including alcohol and illicit drugs).
- Allergies or Physical Discomfort: Patients with severe allergic reactions to materials potentially used in art therapy (e.g., paint, clay, musical...
See the full eligibility criteria
Who can join
- Study Participants: Stroke patients aged 40-75. Patients in this age group generally have a higher incidence of stroke and show relatively higher plasticity during the rehabilitation process.
- Type of Stroke: First occurrence of ischemic or hemorrhagic stroke, confirmed by imaging (CT or MRI).
- Time Since Stroke Onset: Between 2 weeks and 3 months post-stroke (broadly defined subacute phase).
- Severity of Stroke Sequelae: Stroke sequelae should be mild to moderate (Modified Rankin Scale score of 2 to 3).
- Cognitive Ability: Participants must have basic cognitive function and be able to understand and comply with research requirements.
- Emotional Status: Participants' levels of depression, anxiety, or stress should be mild to moderate at the start of the study.
- Language and Communication Skills: Participants must possess basic language expression and comprehension abilities to engage in and understand interactions during art therapy sessions.
- Physical Condition: Participants must have the basic physical functions necessary to participate in art therapy, such as the ability to perform simple limb movements and activities.
- Living Environment: Participants should reside in an area that allows them to regularly travel to the treatment site and have a relatively stable living environment.
- Consent to Participate: Both the patient and their family members must fully understand the purpose, process, and potential risks of the study and be willing to sign an informed consent form.
- No Prior Psychological or Art Therapy: Participants must not have received any form of psychological therapy, art therapy, or similar rehabilitation intervention in the past 6 months to exclude the impact of other...
What rules you out
- Severe Mental Illness: A history or current diagnosis of severe mental disorders (e.g., schizophrenia, bipolar disorder) or a current severe level of depression, anxiety, or stress.
- Severe Comorbidities: Patients with serious physical illnesses, such as advanced cancer, severe heart disease (e.g., heart failure, acute coronary syndrome), chronic renal failure, or severe chronic respiratory...
- Severe Sensory Impairments: Patients with serious sensory impairments, such as blindness, profound hearing loss, or uncorrectable sensory deficits.
- Severe Language Impairments: Patients with severe aphasia or speech communication disorders that impede effective communication or expression.
- Substance Dependence or Abuse History: Patients with a current history of substance dependence or abuse (including alcohol and illicit drugs).
- Allergies or Physical Discomfort: Patients with severe allergic reactions to materials potentially used in art therapy (e.g., paint, clay, musical instruments) or a history of physical discomfort caused by similar...
- Lack of Willingness to Participate: Patients or their family members show insufficient willingness to participate in the study or are unable to provide written informed consent.
- Other Potential Influencing Factors: Any other factors not listed but considered by researchers to potentially affect patient participation or study outcomes.
The study team makes the final eligibility decision.
Where it is enrolling
- Jiamusi, Heilongjiang, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Jiamusi, Heilongjiang, China. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.